Ovid Therapeutics (OVID) vs YD Bio Limited (YDES)

Ovid Therapeutics OVID 2.87 +11.24%
YD Bio Limited YDES 6.01 −16.30%

Ovid Therapeutics and YD Bio Limited are both Biotechnology companies. Ovid Therapeutics and YD Bio Limited are of similar size ($508.7M and $503.9M).

Metric	OVID	YDES	Biotechnology median
P/E	n/m	—	10.60
P/S	72.14	—	9.40
P/B	2.70	—	2.13
Price to free cash flow	n/m	—	25.18
EV/EBITDA	n/m	—	0.66
EV/Sales	58.65	—	9.02
Earnings yield	(7.85%)	—	(32.88%)
Free cash flow yield	(9.69%)	—	(23.13%)

Metric	OVID	YDES	Biotechnology median
Gross margin	100.00%	—	68.51%
Operating margin	(742.97%)	—	0.00%
Net margin	(439.11%)	—	0.00%
Free cash flow margin	(697.30%)	—	0.00%
Return on equity	(25.97%)	—	(51.96%)
Return on assets	(22.30%)	—	(46.06%)
Return on invested capital	(35.11%)	—	0.00%

Metric	OVID	YDES	Biotechnology median
Revenue growth (TTM)	1,333.39%	—	6.76%
EPS growth (last fiscal year)	37.84%	—	29.88%
Revenue growth, 5-year CAGR	(10.48%)	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	OVID	YDES	Biotechnology median
Debt to equity	0.05	—	0.00
Current ratio	12.39	—	4.97
Net debt to EBITDA	1.37	—	1.01

Metric	OVID	YDES	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	OVID	YDES	Biotechnology median
Market cap	503.87m	508.65m	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack